EDGEMOND JAMES sold UTHR
May 18, 2026 · Form 4 insider transaction
EDGEMOND JAMES sold 40 shares of United Therapeutics Corporation at $570.18 per share, a transaction worth $22.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
40
Price
$570.18
Total value
$22.8K
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 18, 2026
Filing dateMay 19, 2026
Shares owned after18,876
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.